4-[6-(4-Methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2-nitrobenzenamine, 98%, 250mg

(4-fluoro-3-morpholinophenyl)boronic acid, 95.0%, 100mg

(R)-(3-Pyrrolidin-2-yl-propyl)-carbamic acid tert-butyl ester, 95.0%, 500mg

RAVUCONAZOLE, 95%, 5g

tert-Butyl (6S,8aR)-6-(hydroxymethyl)hexahydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, 97%, 250mg

10-BROMO-3-(2-HYDROXYETHYL)-3-AZATRICYCLO[7.3.1.0]TRIDECA-1(13),5,7,9,11-PENTAENE-2,4-DIONE, 95.0%, 250mg

4-Chloro-6-hydrazinyl-2-MethylpyriMidine, 95%, 250mg

Ethylene Glycol, min 99%, for synthesis, 10 l, plastic packaging.

3-Bromo-5,6-dimethylpyrazolo[1,5-a]pyrimidin-7(4H)-one, 95.0%, 250mg

2,4-Dichloro-pyrrolo[2,1-f][1,2,4]triazine, 95.0%, 1g

Ethyl 5-bromo-1-(3-chlorophenyl)-1H-pyrazole-4-carboxylate, 95+%, 500mg

4-Bromoquinolin-3-amine, 97%, 500mg

tert-Butyl ((2S,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)carbamate, 98%, 100mg